Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Shuganjieyu Capsules for early mild-to-moderate post-stroke depression
ChiCTR2300071000Phase 4Not yet recruiting
- Sponsor
- Tongji Medical College of Huazhong University of Science and Technology
- Start
- Apr 2023
- Modality
- Small Molecules, Device-based Delivery → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4 trial of Shugan Jieyu, sponsored by Tongji Medical College of Huazhong University of Science and Technology. Planned start Apr 2023; status: not yet recruiting.
02
Drugs
Shugan Jieyu
Beyond the preview
Go deeper on ChiCTR2300071000.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300071000.